Cargando…

Effect of age on the prognosis of intrahepatic cholangiocarcinoma

BACKGROUND/AIMS: Intrahepatic cholangiocarcinoma (iCCA) is a subgroup of cholangiocarcinoma and is the second- most-common primary hepatic tumor. Several predictive and prognostic factors have been analyzed; however, in this study we focused on the influence of age. Our aim was to use real-world res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung Hun, Cheon, Young Koog, Lee, Tae Yoon, Lee, Sang Hoon, Chung, Hyunji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816679/ https://www.ncbi.nlm.nih.gov/pubmed/36541019 http://dx.doi.org/10.3904/kjim.2022.146

Ejemplares similares

Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
por: Seo, Jung Woong, et al.
Publicado: (2020)

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
por: Park, Kyun Woo, et al.
Publicado: (2013)

The Role of Photodynamic Therapy for Hilar Cholangiocarcinoma
por: Cheon, Young Koog
Publicado: (2010)

Effect of Rowachol on the Gallbladder Dysmotility Disorder Based on Gallbladder Ejection Fraction
por: Lee, Sang Hoon, et al.
Publicado: (2023)

Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar Cholangiocarcinoma
por: Hong, Mi Jin, et al.
Publicado: (2014)

The Neutrophil-Lymphocyte Ratio as an Early Predictive Marker of the Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
por: Lee, Sang Hoon, et al.
Publicado: (2021)

Intrahepatic cholangiocarcinoma arising in Caroli's disease
por: Jang, Min Hye, et al.
Publicado: (2014)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones
por: Choi, Jung-Hye, et al.
Publicado: (2021)

A Case of Clonorchiasis with Focal Intrahepatic Duct Dilatation Mimicking an Intrahepatic Cholangiocarcinoma
por: Kim, Bong Gap, et al.
Publicado: (2011)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
por: Lee, Kyung-Hun, et al.
Publicado: (2015)

High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
por: Huh, Gunn, et al.
Publicado: (2020)

Genetic features associated with (18)F-FDG uptake in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2019)

Clinical Significance of the Neutrophil–Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Cholangitis
por: Lee, Sang-Hoon, et al.
Publicado: (2022)

Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection
por: Yoo, Tae, et al.
Publicado: (2015)

The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma
por: Wang, Jianping, et al.
Publicado: (2023)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

Prognostic factors predicting survival rate over 10 years of patients with intrahepatic cholangiocarcinoma after hepatic resection
por: Ma, Chung Hyeun, et al.
Publicado: (2020)

Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging
por: Kim, Yeun‐Yoon, et al.
Publicado: (2021)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Synchronous occurrence of gastrointestinal stromal tumor and intrahepatic cholangiocarcinoma: A case report
por: NAM, SEUNG-JOO, et al.
Publicado: (2015)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020)

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2021)

Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations
por: Kim, Young-Ho, et al.
Publicado: (2016)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma
por: Hung, Tsai‐Hsien, et al.
Publicado: (2021)

Clinical Role of Contrast-Enhanced Harmonic Endoscopic Ultrasound in Differentiating Solid Lesions of the Pancreas: A Single-Center Experience in Korea
por: Lee, Tae Yoon, et al.
Publicado: (2013)

Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
por: Kim, Si-Young, et al.
Publicado: (2021)

Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
por: Nam, Kwangwoo, et al.
Publicado: (2017)

Successful treatment of tracheoesophageal fistula using a covered esophageal stent
por: Kim, Jung Hun, et al.
Publicado: (2019)

Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
por: Lee, Hee Seung, et al.
Publicado: (2023)

Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma
por: Yang, So Mi, et al.
Publicado: (2023)

A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model
por: Lee, Eung Suk, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cvpemschrc6ehu51pr2d1h2v45